$2.26 Billion is the total value of PFM Health Sciences, LP's 78 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 39.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | HORIZON THERAPEUTICS PUB L | $119,163,418 | -4.1% | 1,091,840 | 0.0% | 5.26% | +18.3% | |
| LLY | LILLY ELI & CO | $102,559,979 | -6.1% | 298,643 | 0.0% | 4.53% | +15.8% | |
| PEN | PENUMBRA INC | $100,336,761 | +25.3% | 360,030 | 0.0% | 4.43% | +54.5% | |
| CYTK | CYTOKINETICS INC | $84,439,989 | -23.2% | 2,399,545 | 0.0% | 3.73% | -5.3% | |
| HUM | HUMANA INC | $80,618,400 | -5.2% | 166,066 | 0.0% | 3.56% | +16.9% | |
| CNC | CENTENE CORP DEL | $70,319,861 | -22.9% | 1,112,480 | 0.0% | 3.11% | -4.9% | |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $60,212,596 | +30.2% | 485,468 | -1.7% | 2.66% | +60.6% |
| Sell | OAK STR HEALTH INCnote 3/1 | $57,937,296 | +20.7% | 58,500,000 | -7.1% | 2.56% | +48.9% | |
| UNH | UNITEDHEALTH GROUP INC | $54,852,104 | -10.9% | 116,067 | 0.0% | 2.42% | +10.0% | |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $53,661,408 | +35.7% | 648,633 | +22.4% | 2.37% | +67.4% |
| DXCM | Buy | DEXCOM INC | $49,238,943 | +221.0% | 423,816 | +212.9% | 2.18% | +296.2% |
| MRK | Buy | MERCK & CO INC | $49,058,344 | +20.3% | 461,118 | +25.4% | 2.17% | +48.3% |
| CAH | CARDINAL HEALTH INC | $48,303,617 | -1.8% | 639,783 | 0.0% | 2.13% | +21.1% | |
| ABBV | Sell | ABBVIE INC | $46,042,471 | -13.5% | 288,903 | -12.3% | 2.03% | +6.7% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $45,694,131 | +50.5% | 178,863 | +56.3% | 2.02% | +85.6% |
| SGEN | Buy | SEAGEN INC | $44,722,181 | +80.9% | 220,883 | +14.8% | 1.98% | +123.2% |
| DHR | DANAHER CORPORATION | $44,280,908 | -5.0% | 175,690 | 0.0% | 1.96% | +17.1% | |
| HUM | New | HUMANA INCput | $42,671,934 | – | 87,900 | +100.0% | 1.88% | – |
| QURE | Sell | UNIQURE NV | $42,496,810 | -18.6% | 2,110,070 | -8.4% | 1.88% | +0.4% |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $41,113,290 | -11.0% | 1,946,652 | +7.3% | 1.82% | +9.8% |
| IQV | Sell | IQVIA HLDGS INC | $39,984,249 | -14.8% | 201,037 | -12.2% | 1.77% | +5.1% |
| HCA | Buy | HCA HEALTHCARE INC | $39,156,480 | +77.5% | 148,500 | +61.5% | 1.73% | +118.9% |
| ARGX | ARGENX SEsponsored adr | $39,021,049 | -1.6% | 104,732 | 0.0% | 1.72% | +21.3% | |
| MOH | MOLINA HEALTHCARE INC | $38,459,445 | -19.0% | 143,779 | 0.0% | 1.70% | -0.1% | |
| MCK | MCKESSON CORP | $37,674,007 | -5.1% | 105,811 | 0.0% | 1.66% | +17.1% | |
| PRTA | Sell | PROTHENA CORP PLC | $37,542,245 | -28.8% | 774,546 | -11.5% | 1.66% | -12.2% |
| AXSM | Sell | AXSOME THERAPEUTICS INC | $37,383,076 | -55.6% | 606,081 | -44.5% | 1.65% | -45.3% |
| BDX | New | BECTON DICKINSON & CO | $37,381,758 | – | 151,013 | +100.0% | 1.65% | – |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $37,330,680 | -7.8% | 3,805,370 | 0.0% | 1.65% | +13.7% | |
| TMO | THERMO FISHER SCIENTIFIC INC | $35,817,361 | +4.7% | 62,143 | 0.0% | 1.58% | +29.1% | |
| ISEE | Buy | IVERIC BIO INC | $35,655,201 | +81.5% | 1,465,483 | +59.7% | 1.58% | +124.0% |
| UNH | New | UNITEDHEALTH GROUP INCput | $30,576,573 | – | 64,700 | +100.0% | 1.35% | – |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $29,701,364 | +69.4% | 233,685 | +87.8% | 1.31% | +108.9% |
| WAT | WATERS CORP | $29,298,429 | -9.6% | 94,624 | 0.0% | 1.29% | +11.5% | |
| AVTR | Sell | AVANTOR INC | $28,567,032 | -15.7% | 1,351,326 | -15.9% | 1.26% | +4.0% |
| RCUS | Sell | ARCUS BIOSCIENCES INC | $28,453,433 | -49.1% | 1,559,947 | -42.3% | 1.26% | -37.2% |
| Buy | CARIBOU BIOSCIENCES INC | $26,614,347 | -5.0% | 5,012,118 | +12.4% | 1.18% | +17.1% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $25,104,283 | -1.9% | 138,209 | +6.1% | 1.11% | +20.9% |
| PNT | Sell | POINT BIOPHARMA GLOBAL INC | $23,298,823 | -31.0% | 3,204,790 | -30.8% | 1.03% | -15.0% |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $22,767,603 | – | 472,161 | +100.0% | 1.01% | – |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $22,465,054 | – | 310,935 | +100.0% | 0.99% | – |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $21,670,770 | – | 202,115 | +100.0% | 0.96% | – |
| THC | Buy | TENET HEALTHCARE CORP | $21,209,434 | +70.8% | 356,941 | +40.2% | 0.94% | +110.6% |
| ICUI | New | ICU MED INC | $20,241,087 | – | 122,703 | +100.0% | 0.89% | – |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $18,750,383 | +13.9% | 284,269 | -10.7% | 0.83% | +40.3% |
| BCRX | BIOCRYST PHARMACEUTICALS INC | $18,034,508 | -27.4% | 2,162,411 | 0.0% | 0.80% | -10.3% | |
| NEVRO CORPnote 2.750% 4/0 | $16,450,000 | +2.5% | 17,500,000 | 0.0% | 0.73% | +26.4% | ||
| Sell | ARCELLX INC | $16,200,391 | -15.2% | 525,816 | -14.7% | 0.72% | +4.7% | |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $15,516,198 | -51.7% | 159,566 | -48.6% | 0.68% | -40.4% |
| Sell | BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $15,427,185 | -59.6% | 15,000,000 | -58.2% | 0.68% | -50.2% | |
| ANTM | Sell | ELEVANCE HEALTH INC | $14,981,989 | -56.5% | 32,583 | -51.5% | 0.66% | -46.3% |
| BLUE | Buy | BLUEBIRD BIO INC | $14,582,787 | +760.6% | 4,585,782 | +1772.8% | 0.64% | +955.7% |
| ERASCA INC | $14,440,355 | -30.2% | 4,797,460 | 0.0% | 0.64% | -13.8% | ||
| ICLR | Sell | ICON PLC | $13,758,827 | -13.3% | 64,417 | -21.2% | 0.61% | +7.0% |
| LLY | New | LILLY ELI & COcall | $13,633,774 | – | 39,700 | +100.0% | 0.60% | – |
| EPIX | Buy | ESSA PHARMA INC | $12,359,539 | +27.6% | 4,161,461 | +8.2% | 0.55% | +57.3% |
| MRTX | New | MIRATI THERAPEUTICS INC | $11,858,487 | – | 318,948 | +100.0% | 0.52% | – |
| GBIO | Sell | GENERATION BIO CO | $11,387,677 | -0.2% | 2,648,297 | -8.8% | 0.50% | +23.0% |
| Sell | PROCEPT BIOROBOTICS CORP | $9,081,809 | -57.8% | 319,782 | -38.2% | 0.40% | -47.9% | |
| EDIT | Sell | EDITAS MEDICINE INC | $7,545,757 | -42.0% | 1,040,794 | -29.0% | 0.33% | -28.5% |
| IMVT | New | IMMUNOVANT INC | $7,172,305 | – | 462,431 | +100.0% | 0.32% | – |
| THC | Sell | TENET HEALTHCARE CORPcall | $6,571,852 | -40.4% | 110,600 | -51.0% | 0.29% | -26.6% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $6,531,902 | -7.6% | 5,992,571 | +23.7% | 0.29% | +13.8% |
| OM | New | OUTSET MED INC | $5,979,669 | – | 324,982 | +100.0% | 0.26% | – |
| HOWL | Buy | WEREWOLF THERAPEUTICS INC | $5,764,772 | +117.4% | 2,217,220 | +71.4% | 0.26% | +168.4% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $3,584,261 | +419.8% | 100,147 | +472.7% | 0.16% | +532.0% |
| CELC | Sell | CELCUITY INC | $3,187,391 | -68.1% | 310,965 | -56.3% | 0.14% | -60.5% |
| BLU | Buy | BELLUS HEALTH INC NEW | $3,166,654 | +503.2% | 439,813 | +588.7% | 0.14% | +636.8% |
| VERV | Sell | VERVE THERAPEUTICS INC | $2,683,375 | -36.2% | 186,087 | -14.4% | 0.12% | -21.2% |
| CMPS | Sell | COMPASS PATHWAYS PLCsponsored ads | $2,443,416 | -40.3% | 246,064 | -51.7% | 0.11% | -26.5% |
| INBX | New | INHIBRX INC | $2,291,705 | – | 121,447 | +100.0% | 0.10% | – |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $1,993,989 | -31.3% | 418,027 | +25.3% | 0.09% | -15.4% |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $1,760,865 | -73.4% | 2,176,594 | -21.6% | 0.08% | -67.1% |
| VECT | Buy | VECTIVBIO HLDG AG | $1,122,656 | +407.3% | 131,922 | +416.5% | 0.05% | +525.0% |
| IO BIOTECH INC | $951,825 | -18.5% | 507,640 | 0.0% | 0.04% | 0.0% | ||
| KROS | Buy | KEROS THERAPEUTICS INC | $868,945 | +13.1% | 20,350 | +27.2% | 0.04% | +35.7% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $867,956 | +918.5% | 142,055 | +965.1% | 0.04% | +1166.7% |
| SANA | Sell | SANA BIOTECHNOLOGY INC | $45,669 | -81.6% | 13,966 | -77.8% | 0.00% | -77.8% |
| Exit | BIOHAVEN LTD | $0 | – | -10,988 | -100.0% | -0.01% | – | |
| JNCE | Exit | JOUNCE THERAPEUTICS INC | $0 | – | -345,926 | -100.0% | -0.01% | – |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -70,922 | -100.0% | -0.05% | – |
| LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -13,561 | -100.0% | -0.11% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -130,366 | -100.0% | -0.20% | – |
| PRTA | Exit | PROTHENA CORP PLCcall | $0 | – | -152,300 | -100.0% | -0.33% | – |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -565,239 | -100.0% | -0.44% | – |
| LUNG | Exit | PULMONX CORP | $0 | – | -1,455,770 | -100.0% | -0.44% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -72,820 | -100.0% | -0.57% | – |
| ABBV | Exit | ABBVIE INCcall | $0 | – | -100,000 | -100.0% | -0.58% | – |
| JAZZ | Exit | JAZZ PHARMACEUTICALS PLCput | $0 | – | -128,500 | -100.0% | -0.73% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INCcall | $0 | – | -299,000 | -100.0% | -0.83% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -137,746 | -100.0% | -0.87% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -243,000 | -100.0% | -0.90% | – |
| A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -183,504 | -100.0% | -0.98% | – |
| UNH | Exit | UNITEDHEALTH GROUP INCcall | $0 | – | -69,600 | -100.0% | -1.32% | – |
| AZN | Exit | ASTRAZENECA PLCsponsored adr | $0 | – | -576,800 | -100.0% | -1.40% | – |
| BIIB | Exit | BIOGEN INC | $0 | – | -155,659 | -100.0% | -1.54% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -141,300 | -100.0% | -1.68% | – |
| PEN | Exit | PENUMBRA INCcall | $0 | – | -237,500 | -100.0% | -1.89% | – |
| LH | Exit | LABORATORY CORP AMER HLDGScall | $0 | – | -225,000 | -100.0% | -1.90% | – |
| JNJ | Exit | JOHNSON & JOHNSONput | $0 | – | -450,000 | -100.0% | -2.85% | – |
| MRK | Exit | MERCK & CO INCcall | $0 | – | -871,500 | -100.0% | -3.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.